GYRE - Gyre Therapeutics Inc
IEX Last Trade
13.385
-0.345 -2.578%
Share volume: 32,987
Last Updated: Fri 30 Aug 2024 07:58:15 PM CEST
Research and Development in Biotechnology (except Nanobiotechnology):
0.21%
PREVIOUS CLOSE
CHG
CHG%
$13.73
-0.35
-2.51%
View ratios
| Fiscal Date | 2022-06-30 | 2022-09-30 | 2022-12-31 | 2023-03-31 | 2023-06-30 | 2023-09-30 | 2023-12-31 | 2024-03-31 | |
|---|---|---|---|---|---|---|---|---|---|
| Fiscal Quarter | Q2 2022 | Q3 2022 | Q4 2022 | Q1 2023 | Q2 2023 | Q3 2023 | Q4 2023 | Q1 2024 | |
| Report Date | 2022-08-15 | 2022-11-14 | 2023-03-30 | 2023-05-15 | 2023-08-14 | 2023-10-26 | 2024-03-27 | 2024-05-13 | |
| Total revenue | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 113.450 M | 27.172 M | |
| Cost of revenue | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 4.636 M | 979.000 K | |
| Gross profit | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 108.814 M | 26.193 M | |
| nan% | nan% | nan% | nan% | nan% | inf% | -75.93% | |||
| Operating expenses | 5.715 M | 5.166 M | 4.825 M | 4.558 M | 2.543 M | 2.823 M | 79.677 M | 18.122 M | |
| Selling general and admin | 3.844 M | 4.363 M | 4.165 M | 3.970 M | 2.225 M | 2.408 M | 67.218 M | 15.940 M | |
| Research and development | 1.871 M | 803.000 K | 660.000 K | 588.000 K | 318.000 K | 415.000 K | 12.459 M | 2.182 M | |
| Total expenses | 5.715 M | 5.166 M | 4.825 M | 4.558 M | 2.543 M | 2.823 M | 84.313 M | 19.101 M | |
| -9.61% | -6.60% | -5.53% | -44.21% | 11.01% | 2,886.65% | -77.35% | |||
| Operating income | -5.715 M | -5.166 M | -4.825 M | -4.558 M | -2.543 M | -2.823 M | 29.137 M | 8.071 M | |
| Ebit | -5.715 M | -5.166 M | -4.825 M | -4.558 M | -2.543 M | -2.823 M | 29.137 M | 8.071 M | |
| Pretax income | 51.632 M | -4.884 M | -40.106 M | 274.000 K | -2.470 M | -1.576 M | -73.193 M | 12.481 M | |
| -109.46% | 721.17% | -100.68% | -1,001.46% | -36.19% | 4,544.23% | -117.05% | |||
| Income tax | 0.000 | 0.000 | 348.000 K | 14.000 K | 2.000 K | 0.000 | 8.499 M | 2.546 M | |
| Net income basic | 51.632 M | -4.884 M | -40.454 M | 260.000 K | -2.472 M | -1.576 M | -89.145 M | 7.532 M | |
| -109.46% | -728.30% | 100.64% | -1,050.77% | 36.25% | -5,556.41% | 108.45% | |||
| Net income | 51.632 M | -4.884 M | -40.454 M | 260.000 K | -2.472 M | -1.576 M | -89.145 M | 7.532 M | |
| -109.46% | -728.30% | 100.64% | -1,050.77% | 36.25% | -5,556.41% | 108.45% |